Study identifies blood biomarkers to predict risk of cardiovascular disease in patients with rheumatoid arthritis

Rheumatoid arthritis impacts approximately 2 million people in the United States and is associated with increased risk of cardiovascular disease. However, assessing cardiovascular risk is difficult in patients with rheumatoid arthritis because standard clinical assessments based on factors like age, cholesterol, and smoking status tend to underestimate cardiovascular risk in individuals with rheumatoid arthritis.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup